Catecholamine physiology and its implications in patients with COVID-19

In this Personal View, authors discuss the complex interplay between catecholamines and COVID-19, and the management of catecholamine excess states, while referencing relevant insights derived from the study of phaeochromocytoma and paraganglioma.

The Lancet Diabetes & Endocrinology